{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:36:57Z","timestamp":1785346617147,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.resmer.2025.101240","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:26:31Z","timestamp":1765355191000},"page":"101240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Translation into English and republication of: Pneumocystis jirovecii prophylaxis in non-HIV infected individuals: risk assessment and modalities"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1778-4748","authenticated-orcid":false,"given":"Radhika","family":"Sood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-5164","authenticated-orcid":false,"given":"Marco","family":"Marando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1104-8064","authenticated-orcid":false,"given":"Pieter-Jan","family":"Gijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisis","family":"Balmpouzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2156-254X","authenticated-orcid":false,"given":"Pre Anne","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1227-1679","authenticated-orcid":false,"given":"Angela","family":"Koutsokera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7971-5751","authenticated-orcid":false,"given":"Gregory","family":"Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.resmer.2025.101240_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1550-7408.2005.00072.x","article-title":"Pneumocystis and trypanosoma cruzi : nomenclature and typifications","volume":"53","author":"Redhead","year":"2006","journal-title":"J Eukaryot Microbiol"},{"issue":"8","key":"10.1016\/j.resmer.2025.101240_bib0002","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/jof7080625","article-title":"Immune response in pneumocystis infections according to the host immune system status","volume":"7","author":"Charpentier","year":"2021","journal-title":"JoF"},{"issue":"8","key":"10.1016\/j.resmer.2025.101240_bib0003","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1060028016650107","article-title":"Pneumocystis jirovecii pneumonia in the non\u2013HIV-infected population","volume":"50","author":"Avino","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.resmer.2025.101240_bib0004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/CMR.00013-12","article-title":"Colonization by pneumocystis jirovecii and its role in disease","volume":"25","author":"Morris","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.resmer.2025.101240_bib0005","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/319340","article-title":"Search for primary infection by pneumocystis carinii in a cohort of normal, healthy infants","volume":"32","author":"Vargas","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.resmer.2025.101240_bib0006","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.chest.2024.07.140","article-title":"Clinical characteristics and prognosis of patients with severe pneumonia with pneumocystis jirovecii colonization","volume":"167","author":"Jiang","year":"2025","journal-title":"CHEST"},{"issue":"9","key":"10.1016\/j.resmer.2025.101240_bib0007","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkw156","article-title":"ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Alanio","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.resmer.2025.101240_bib0008","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.chest.2024.01.015","article-title":"Characteristics and prognosis factors of pneumocystis jirovecii pneumonia according to underlying disease","volume":"165","author":"L\u00e9cuyer","year":"2024","journal-title":"CHEST"},{"key":"10.1016\/j.resmer.2025.101240_bib0009","first-page":"1490","volume":"20","author":"Roux","year":"2014"},{"key":"10.1016\/j.resmer.2025.101240_bib0010","first-page":"185","volume":"44","author":"Roux","year":"2014"},{"issue":"8","key":"10.1016\/j.resmer.2025.101240_bib0011","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/323129","article-title":"Prevention of infection caused by Pneumocystis carinii in transplant recipients","volume":"33","author":"Fishman","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.resmer.2025.101240_bib0012","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"SUPPL.4","key":"10.1016\/j.resmer.2025.101240_bib0013","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12119","article-title":"Pneumocystis pneumonia in solid organ transplantation","volume":"13","author":"Martin","year":"2013","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.resmer.2025.101240_bib0014","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1164\/ajrccm\/137.6.1268","article-title":"Unexpectedly high incidence of pneumocystis carinii infection after lung-heart transplantation: implications for lung defense and allograft survival","volume":"137","author":"Gryzan","year":"1988","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"10.1016\/j.resmer.2025.101240_bib0015","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00007890-199203000-00019","article-title":"Trimethoprim-sulfamethoxazole prophylaxis for pneumocystis carinii infections in heart-lung and lung transplantation\u2014how effective and for how long?","volume":"53","author":"Kramer","year":"1992","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.resmer.2025.101240_bib0016","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007890-198606000-00012","article-title":"Infections in heart-lung transplant recipients","volume":"41","author":"Dummer","year":"1986","journal-title":"Transplantation"},{"issue":"895","key":"10.1016\/j.resmer.2025.101240_bib0017","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.53738\/REVMED.2024.20.895.2110","article-title":"Prophylaxie de l\u2019infection \u00e0 [i]Pneumocystis jirovecii[\/i] chez les patients non VIH - \u00e9valuation du risque et des modalit\u00e9s","volume":"20","author":"Sood","year":"2024","journal-title":"Rev M\u00e9d Suisse"},{"issue":"4","key":"10.1016\/j.resmer.2025.101240_bib0018","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/cid\/ciab474","article-title":"Genetic and epidemiologic analyses of an outbreak of pneumocystis jirovecii pneumonia among kidney transplant recipients in the United States","volume":"74","author":"Azar","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.resmer.2025.101240_bib0019","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00002030-199903110-00020","article-title":"Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients","volume":"13","author":"Nevez","year":"1999","journal-title":"Aids"},{"issue":"2","key":"10.1016\/j.resmer.2025.101240_bib0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3201\/eid1102.040487","article-title":"Pneumocystis jirovecii in general population","volume":"11","author":"Medrano","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.resmer.2025.101240_bib0021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1469-0691.2005.01337.x","article-title":"Pneumocystis jirovecii colonisation in patients with interstitial lung disease","volume":"12","author":"Vidal","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.resmer.2025.101240_bib0022","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12890-020-1111-4","article-title":"Pneumocystis jirovecii colonization and its association with pulmonary diseases: a multicenter study based on a modified loop-mediated isothermal amplification assay","volume":"20","author":"Xue","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1016\/j.resmer.2025.101240_bib0023","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1164\/rccm.200401-094OC","article-title":"Association of chronic obstructive pulmonary disease severity and pneumocystis colonization","volume":"170","author":"Morris","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.resmer.2025.101240_bib0024","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/jof7121036","article-title":"Is it possible to differentiate pneumocystis jirovecii pneumonia and colonization in the immunocompromised patients with pneumonia?","volume":"7","author":"Aguilar","year":"2021","journal-title":"JoF"},{"issue":"5","key":"10.1016\/j.resmer.2025.101240_bib0025","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":"Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"10.1016\/j.resmer.2025.101240_bib0026","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1399-3062.2012.00739.x","article-title":"Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV -uninfected persons","volume":"14","author":"McKinnell","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"24","key":"10.1016\/j.resmer.2025.101240_bib0027","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2025.101240_bib0028","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/jof1030293","article-title":"Pneumocystis pneumonia in solid-organ transplant recipients","volume":"1","author":"Iriart","year":"2015","journal-title":"J Fungi"},{"issue":"5","key":"10.1016\/j.resmer.2025.101240_bib0029","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2017-211796","article-title":"Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids","volume":"77","author":"Park","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resmer.2025.101240_bib0030","doi-asserted-by":"crossref","unstructured":"Green H., Paul M., Vidal L., Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. In: The Cochrane Collaboration, editor Cochrane database of systematic reviews [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2007. p. CD005590.pub2. Available from: https:\/\/doi.wiley.com\/10.1002\/14651858.CD005590.pub2","DOI":"10.1002\/14651858.CD005590.pub2"},{"issue":"12","key":"10.1016\/j.resmer.2025.101240_bib0031","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.amjmed.2014.07.010","article-title":"Incidence of pneumocystis jiroveci pneumonia among groups at risk in HIV-negative Patients","volume":"127","author":"Fillatre","year":"2014","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.resmer.2025.101240_bib0032","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13075-019-1996-6","article-title":"Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids\u2014Clinical implication of primary prophylaxis using trimethoprim\u2013sulfamethoxazole","volume":"21","author":"Park","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.resmer.2025.101240_bib0033","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0954-6111(93)90008-N","article-title":"DNA amplification by the polymerase chain reaction to detect sub-clinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms","volume":"87","author":"Leigh","year":"1993","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.resmer.2025.101240_bib0034","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3899\/jrheum.081270","article-title":"a followup study of asymptomatic carriers of pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis","volume":"36","author":"Mori","year":"2009","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.resmer.2025.101240_bib0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/thx.2007.088104","article-title":"Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia","volume":"63","author":"Davis","year":"2008","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.resmer.2025.101240_bib0036","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3201\/eid1010.030994","article-title":"Dihydropteroate synthase gene mutations in pneumocystis and sulfa resistance","volume":"10","author":"Huang","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.resmer.2025.101240_bib0037","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/JCM.03567-13","article-title":"Use and Limits of (1-3)-\u03b2- d -glucan assay (Fungitell), compared to galactomannan determination (platelia aspergillus), for diagnosis of invasive aspergillosis","volume":"52","author":"Sulahian","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.resmer.2025.101240_bib0038","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","article-title":"A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-\u03b2-d-glucan for invasive fungal infection: focus on cutoff levels","volume":"48","author":"He","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"issue":"2","key":"10.1016\/j.resmer.2025.101240_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246296","article-title":"Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness","volume":"16","author":"Kim","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.resmer.2025.101240_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.729193","article-title":"Quantitative PCR to discriminate between pneumocystis pneumonia and colonization in HIV and Non-HIV immunocompromised patients","volume":"12","author":"Sarasombath","year":"2021","journal-title":"Front Microbiol"},{"issue":"6","key":"10.1016\/j.resmer.2025.101240_bib0041","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00277-021-04452-9","volume":"100","author":"Classen","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.resmer.2025.101240_bib0042","article-title":"Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: a case-control study on epidemiology and risk factors on behalf of the infectious diseases working party of the european society for blood and marrow transplantation","author":"Robin","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.resmer.2025.101240_bib0043","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcyt.2019.11.002","article-title":"High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era","volume":"22","author":"Evernden","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.resmer.2025.101240_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106019","article-title":"Pneumocystis pneumonia after lung transplantation: a retrospective multicenter study","volume":"169","author":"Delbove","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2025.101240_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2018.02.009","article-title":"ESCMID study group for infections in compromised hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)","author":"Reinwald","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.resmer.2025.101240_bib0046","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2169\/internalmedicine.7485-21","article-title":"Pneumocystis pneumonia in a patient with ovarian cancer receiving olaparib therapy","volume":"61","author":"Himeji","year":"2022","journal-title":"Intern Med"},{"issue":"Supplement_2","key":"10.1016\/j.resmer.2025.101240_bib0047","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/clinids\/17.Supplement_2.S416","article-title":"Pneumocystis carinii pneumonia in patients without AIDS","volume":"17","author":"Sepkowitz","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.resmer.2025.101240_bib0048","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/CMR.17.4.770-782.2004","article-title":"Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients","volume":"17","author":"Rodriguez","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"10.1016\/j.resmer.2025.101240_bib0049","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/art.42541","article-title":"Risk\u2013benefit analysis of primary prophylaxis against pneumocystis jirovecii pneumonia in patients with rheumatic diseases receiving rituximab","volume":"75","author":"Park","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.resmer.2025.101240_bib0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.12-0477","article-title":"Pneumocystis pneumonia in patients treated with rituximab","volume":"144","author":"Martin-Garrido","year":"2013","journal-title":"Chest"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259004122500087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259004122500087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:10:45Z","timestamp":1780920645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259004122500087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":50,"alternative-id":["S259004122500087X"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101240","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translation into English and republication of: Pneumocystis jirovecii prophylaxis in non-HIV infected individuals: risk assessment and modalities","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101240"}}